Global Viral Sample Preservation Solution Market Growth 2026-2032
Description
The global Viral Sample Preservation Solution market size is predicted to grow from US$ 203 million in 2025 to US$ 288 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.
Viral Sample Preservation Solution is an integrated technical system combining specialized preservatives, sterile containers, and standardized operating procedures, designed to maintain the integrity of viral particles (viability) or nucleic acids (RNA/DNA) during collection, transport, and storage. It includes inactivated and non-inactivated types, adapts to different temperature conditions (ambient, low-temperature, ultra-low-temperature), and prevents sample degradation or contamination, providing reliable sample support for viral detection, scientific research, and vaccine development.
In 2025, global Viral Sample Preservation Solution production reached approximately 52 million units, with an average global market price of around US$ 4 per unit.
The Viral Sample Preservation Solution market is experiencing significant growth driven by several key factors: Market Drivers: Rising burden of infectious diseases: Increasing prevalence of various viral diseases, including COVID-19, influenza, and emerging viral threats, fuels demand for efficient sample preservation for diagnostics and research. Expanding laboratory testing and research activities: Growing focus on public health surveillance, vaccine development, and antiviral research necessitates reliable viral sample preservation. Focus on biosafety and sample integrity: Concerns about sample degradation and potential loss of viral RNA/DNA during transport and storage drive demand for high-quality preservation solutions. Technological advancements: Development of novel stabilization technologies, inactivation methods, and combination solutions with enhanced efficacy and broader viral compatibility. Increasing awareness and adoption in various settings: Healthcare facilities, research laboratories, and even field workers are recognizing the benefits of using preservation solutions for improved sample handling and testing accuracy. Market Challenges: Regulation and compliance: Stringent regulations governing viral sample handling and transportation require manufacturers to ensure solution compliance and safety. Competition and price sensitivity: Wide range of available solutions creates price competition, influencing purchasing decisions. Developing markets: Limited healthcare infrastructure and awareness in some regions pose challenges for market penetration. Overall, the Viral Sample Preservation Solution market presents promising opportunities for manufacturers, distributors, and research institutions. Focusing on addressing regulatory challenges, developing novel solutions, and providing cost-effective options will be crucial to ensuring the market's sustainable growth and contribution to global health initiatives.
LP Information, Inc. (LPI) ' newest research report, the “Viral Sample Preservation Solution Industry Forecast” looks at past sales and reviews total world Viral Sample Preservation Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected Viral Sample Preservation Solution sales for 2026 through 2032. With Viral Sample Preservation Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Sample Preservation Solution industry.
This Insight Report provides a comprehensive analysis of the global Viral Sample Preservation Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viral Sample Preservation Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Sample Preservation Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Sample Preservation Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Sample Preservation Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Sample Preservation Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Inactivated
Non-inactivated
Segmentation by Preservation Temperature Requirement:
Ambient Temperature Preservation Solution
Low-Temperature Preservation Solution
Ultra-Low Temperature Preservation Solution
Segmentation by Target Sample Type:
Swab Sample Preservation Solution
Tissue Sample Preservation Solution
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Biosigma
BIOBASE
BD
Aptaca
Orient Gene
Mole Bioscience
Biocomma
Beijing Hanbaihan Medical
Darui Biotech
Hangzhou LifeReal Biotechnology
Copan Diagnostics
BioServUK
Guangdong Hybribio Biotech
Haimen Shengbang Laboratory Equipment
Longsee Biomedical
Hangzhou Jiuyang Biotechnology
Jifan Biotechnology (Beijing)
Puritan Medical Products
Cardinal Health
Medline Industries
Shandong Chengwu Medical Products Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global Viral Sample Preservation Solution market?
What factors are driving Viral Sample Preservation Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viral Sample Preservation Solution market opportunities vary by end market size?
How does Viral Sample Preservation Solution break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Viral Sample Preservation Solution is an integrated technical system combining specialized preservatives, sterile containers, and standardized operating procedures, designed to maintain the integrity of viral particles (viability) or nucleic acids (RNA/DNA) during collection, transport, and storage. It includes inactivated and non-inactivated types, adapts to different temperature conditions (ambient, low-temperature, ultra-low-temperature), and prevents sample degradation or contamination, providing reliable sample support for viral detection, scientific research, and vaccine development.
In 2025, global Viral Sample Preservation Solution production reached approximately 52 million units, with an average global market price of around US$ 4 per unit.
The Viral Sample Preservation Solution market is experiencing significant growth driven by several key factors: Market Drivers: Rising burden of infectious diseases: Increasing prevalence of various viral diseases, including COVID-19, influenza, and emerging viral threats, fuels demand for efficient sample preservation for diagnostics and research. Expanding laboratory testing and research activities: Growing focus on public health surveillance, vaccine development, and antiviral research necessitates reliable viral sample preservation. Focus on biosafety and sample integrity: Concerns about sample degradation and potential loss of viral RNA/DNA during transport and storage drive demand for high-quality preservation solutions. Technological advancements: Development of novel stabilization technologies, inactivation methods, and combination solutions with enhanced efficacy and broader viral compatibility. Increasing awareness and adoption in various settings: Healthcare facilities, research laboratories, and even field workers are recognizing the benefits of using preservation solutions for improved sample handling and testing accuracy. Market Challenges: Regulation and compliance: Stringent regulations governing viral sample handling and transportation require manufacturers to ensure solution compliance and safety. Competition and price sensitivity: Wide range of available solutions creates price competition, influencing purchasing decisions. Developing markets: Limited healthcare infrastructure and awareness in some regions pose challenges for market penetration. Overall, the Viral Sample Preservation Solution market presents promising opportunities for manufacturers, distributors, and research institutions. Focusing on addressing regulatory challenges, developing novel solutions, and providing cost-effective options will be crucial to ensuring the market's sustainable growth and contribution to global health initiatives.
LP Information, Inc. (LPI) ' newest research report, the “Viral Sample Preservation Solution Industry Forecast” looks at past sales and reviews total world Viral Sample Preservation Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected Viral Sample Preservation Solution sales for 2026 through 2032. With Viral Sample Preservation Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Sample Preservation Solution industry.
This Insight Report provides a comprehensive analysis of the global Viral Sample Preservation Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viral Sample Preservation Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Sample Preservation Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Sample Preservation Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Sample Preservation Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Sample Preservation Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Inactivated
Non-inactivated
Segmentation by Preservation Temperature Requirement:
Ambient Temperature Preservation Solution
Low-Temperature Preservation Solution
Ultra-Low Temperature Preservation Solution
Segmentation by Target Sample Type:
Swab Sample Preservation Solution
Tissue Sample Preservation Solution
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Biosigma
BIOBASE
BD
Aptaca
Orient Gene
Mole Bioscience
Biocomma
Beijing Hanbaihan Medical
Darui Biotech
Hangzhou LifeReal Biotechnology
Copan Diagnostics
BioServUK
Guangdong Hybribio Biotech
Haimen Shengbang Laboratory Equipment
Longsee Biomedical
Hangzhou Jiuyang Biotechnology
Jifan Biotechnology (Beijing)
Puritan Medical Products
Cardinal Health
Medline Industries
Shandong Chengwu Medical Products Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global Viral Sample Preservation Solution market?
What factors are driving Viral Sample Preservation Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viral Sample Preservation Solution market opportunities vary by end market size?
How does Viral Sample Preservation Solution break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
165 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Viral Sample Preservation Solution by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Viral Sample Preservation Solution by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
